Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
GATX Corp
GATX
$6.45B
| $3.11M | ﹤0.01% |
+39,200
| New | +$2.98M |
|
2102
Climb Global Solutions
CLMB
$497M
| $3.09M | ﹤0.01% |
1,094,452
+51,652
| +5% | +$152K |
|
|
CHMA
2103
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $3.08M | ﹤0.01% |
411,883
+189,500
| +85% | +$1.24M |
|
2104
FTI Consulting
FCN
$4.95B
| $3.07M | ﹤0.01% |
36,600
+4,100
| +13% | +$337K |
|
|
AXE
2105
DELISTED
Anixter International Inc
AXE
| $3.07M | ﹤0.01% |
51,400
+23,800
| +86% | +$1.4M |
|
2106
Enovis
ENOV
$1.69B
| $3.07M | ﹤0.01% |
63,561
-333,669
| -84% | -$16.1M |
|
|
HRC
2107
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.06M | ﹤0.01% |
29,300
-343,200
| -92% | -$34.7M |
|
2108
Atara Biotherapeutics
ATRA
$73.6M
| $3.06M | ﹤0.01% |
+6,086
| New | +$4.3M |
|
2109
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
| $3.05M | ﹤0.01% |
46,300
-3,700
| -7% | -$240K |
|
2110
O-I Glass
OI
$1.13B
| $3.04M | ﹤0.01% |
176,100
-222,000
| -56% | -$3.96M |
|
2111
STAG Industrial
STAG
$7.43B
| $3.04M | ﹤0.01% |
100,500
-248,400
| -71% | -$7.38M |
|
2112
AllianceBernstein
AB
$3.43B
| $3.03M | ﹤0.01% |
102,000
+94,662
| +1,290% | +$2.75M |
|
2113
Data I/O
DAIO
$30M
| $3.02M | ﹤0.01% |
672,042
-13,846
| -2% | -$66.2K |
|
2114
Geospace Technologies
GEOS
$93.1M
| $3.02M | ﹤0.01% |
200,134
+52,400
| +35% | +$721K |
|
2115
Park-Ohio Holdings
PKOH
$568M
| $3.02M | ﹤0.01% |
92,693
+7,993
| +9% | +$272K |
|
|
SAFE
2116
DELISTED
Safehold Inc.
SAFE
| $3.02M | ﹤0.01% |
100,009
+18,204
| +22% | +$484K |
|
2117
8x8 Inc
EGHT
$262M
| $3.02M | ﹤0.01% |
+125,130
| New | +$2.91M |
|
|
DOC
2118
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $3.01M | ﹤0.01% |
172,600
-1,201,197
| -87% | -$21.8M |
|
|
CCRD
2119
DELISTED
CoreCard
CCRD
| $3.01M | ﹤0.01% |
104,497
+72,400
| +226% | +$2.41M |
|
2120
Comp X International
CIX
$350M
| $3M | ﹤0.01% |
177,200
+3,500
| +2% | +$53.9K |
|
|
AGS
2121
DELISTED
PlayAGS
AGS
| $2.99M | ﹤0.01% |
153,900
-25,400
| -14% | -$547K |
|
2122
Lesaka Technologies
LSAK
$399M
| $2.98M | ﹤0.01% |
745,800
-125,600
| -14% | -$451K |
|
2123
Customers Bancorp
CUBI
$2.65B
| $2.97M | ﹤0.01% |
141,420
-139,000
| -50% | -$2.9M |
|
2124
Minerals Technologies
MTX
$2.25B
| $2.97M | ﹤0.01% |
55,500
+33,800
| +156% | +$1.97M |
|
2125
Airgain
AIRG
$72.8M
| $2.97M | ﹤0.01% |
209,824
+190,524
| +987% | +$2.75M |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.